Philina Lee Net Worth & Insider Trades
Philina Lee - CHIEF COMMERCIAL OFFICER, Blueprint Medicines Corp
What is Philina Lee's Net Worth?
The current estimated net worth of Blueprint Medicines Corp's CHIEF COMMERCIAL OFFICER, Philina Lee, is estimated to be about $2.32M . Philina Lee owns about 31,178 units of Blueprint Medicines Corp common stock. Recently at Blueprint Medicines Corp, Philina Lee has sold an estimated value of $76.56K worth.
What is Philina Lee's Past Insider Trading?
Philina Lee's largest sale order was 1,676 units , worth over $76.56K on March 8, 2023. In total, Philina Lee has made about 2 transactions recently at Blueprint Medicines Corp. Philina Lee usually trades in March, with the busiest year in 2023.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Philina Lee
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
InsideArbitrage
What is Philina Lee's' Mailing Address?
- Mailing address is C/o Fusion Pharmaceuticals, Inc. 270 Longwood Road South Hamilton D0 L8P OA6 Bermuda
Blueprint Medicines Corp Executive Compensation
Name |
Year
|
Salary
|
Total
|
|---|---|---|---|
| Jeffrey W. Albers | 2020 | $645,000 | $6,344,667 |
| Jeffrey W. Albers | 2019 | $590,000 | $9,362,371 |
| Jeffrey W. Albers | 2018 | $541,144 | $9,740,799 |
| Michael Landsittel | 2020 | $379,575 | $2,014,974 |
| Michael Landsittel | 2019 | $345,000 | $1,958,720 |
| Michael Landsittel | 2018 | $281,678 | $1,740,610 |
| Fouad Namouni, M.D. | 2020 | $186,154 | $6,668,732 |
| Fouad Namouni, M.D. | 2019 | - | - |
| Fouad Namouni, M.D. | 2018 | - | - |
| Kathryn Haviland | 2020 | $460,944 | $2,363,556 |
| Kathryn Haviland | 2019 | $431,830 | $3,090,423 |
| Kathryn Haviland | 2018 | $392,589 | $2,601,762 |
| Tracey L. McCain, Esq. | 2020 | $453,301 | $2,346,428 |
| Tracey L. McCain, Esq. | 2019 | $437,972 | $2,900,568 |
| Tracey L. McCain, Esq. | 2018 | $425,216 | $2,647,962 |
| No matching records found | |||
Source: https://www.sec.gov/Archives/edgar/data/1597264/000155837021004557/tmb-20210602xdef14a.htm
What are Blueprint Medicines Corp's Past Insider Trades?
Blueprint Medicines Corp's most recent insider trade came on December 6, 2023 by Christopher Murray who sold 600 units worth $42.86K . In the last 8 years, insiders at Blueprint Medicines Corp have sold an estimated value of $180.39M and bought an estimated value of $18.29M worth of shares. Insider trading is most common in March, with the busiest year in 2020. The most active traders at the company are Jeffrey Albers, Kate Haviland, CHIEF EXECUTIVE OFFICER, and Ariel Hurley, PRINCIPAL ACCOUNTING OFFICER .
Blueprint Medicines Corp Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||